Kirk Coleman's most recent trade in Q2 Holdings Inc was a trade of 33,726 Common Stock done . Disclosure was reported to the exchange on March 11, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Q2 Holdings Inc | Kirk L. Coleman | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2026 | 33,726 | 285,534 (0%) | 0% | 0 | Common Stock | |
| Q2 Holdings Inc | Kirk L. Coleman | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2026 | 13,490 | 312,514 (0%) | 0% | 0 | Common Stock | |
| Q2 Holdings Inc | Kirk L. Coleman | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2026 | 13,490 | 299,024 (0%) | 0% | 0 | Common Stock | |
| Q2 Holdings Inc | Kirk L. Coleman | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2026 | 6,746 | 319,260 (0%) | 0% | 0 | Common Stock | |
| Q2 Holdings Inc | Kirk L. Coleman | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 51.35 per share. | 09 Mar 2026 | 10,849 | 251,808 (0%) | 0% | 51.3 | 557,096 | Common Stock |
| Q2 Holdings Inc | Kirk L. Coleman | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 49.75 per share. | 02 Mar 2026 | 31,104 | 262,657 (0%) | 0% | 49.8 | 1,547,424 | Common Stock |
| Q2 Holdings Inc | Kirk L. Coleman | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2026 | 23,556 | 279,767 (0%) | 0% | 0 | Common Stock | |
| Q2 Holdings Inc | Kirk L. Coleman | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2026 | 21,746 | 293,761 (0%) | 0% | 0 | Common Stock | |
| Q2 Holdings Inc | Kirk L. Coleman | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 49.72 per share. | 02 Mar 2026 | 7,752 | 272,015 (0%) | 0% | 49.7 | 385,429 | Common Stock |
| Q2 Holdings Inc | Kirk L. Coleman | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 52.48 per share. | 17 Feb 2026 | 12,917 | 256,211 (0%) | 0% | 52.5 | 677,884 | Common Stock |
| Q2 Holdings Inc | Kirk L. Coleman | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 73.68 per share. | 10 Dec 2025 | 8,559 | 269,128 (0%) | 0% | 73.7 | 630,627 | Common Stock |
| Q2 Holdings Inc | Kirk L. Coleman | President | Sale of securities on an exchange or to another person at price $ 80.93 per share. | 08 Sep 2025 | 39,508 | 277,687 (0%) | 0% | 80.9 | 3,197,382 | Common Stock |
| Q2 Holdings Inc | Kirk L. Coleman | President | Sale of securities on an exchange or to another person at price $ 80.04 per share. | 22 Aug 2025 | 5,985 | 317,195 (0%) | 0% | 80.0 | 479,039 | Common Stock |
| Q2 Holdings Inc | Kirk L. Coleman | President | Sale of securities on an exchange or to another person at price $ 90.55 per share. | 10 Jun 2025 | 3,574 | 323,180 (0%) | 0% | 90.6 | 323,626 | Common Stock |
| Q2 Holdings Inc | Kirk L. Coleman | President | Sale of securities on an exchange or to another person at price $ 87.45 per share. | 02 Jun 2025 | 7,093 | 326,754 (0%) | 0% | 87.5 | 620,283 | Common Stock |
| Q2 Holdings Inc | Kirk L. Coleman | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 30,443 | 303,404 (0%) | 0% | 0 | Common Stock | |
| Q2 Holdings Inc | Kirk L. Coleman | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 15,222 | 318,626 (0%) | 0% | 0 | Common Stock | |
| Q2 Holdings Inc | Kirk L. Coleman | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 15,221 | 333,847 (0%) | 0% | 0 | Common Stock | |
| Q2 Holdings Inc | Kirk L. Coleman | President | Sale of securities on an exchange or to another person at price $ 80.89 per share. | 04 Mar 2025 | 19,467 | 272,961 (0%) | 0% | 80.9 | 1,574,686 | Common Stock |
| Q2 Holdings Inc | Kirk L. Coleman | President | Sale of securities on an exchange or to another person at price $ 88.75 per share. | 21 Feb 2025 | 45,215 | 292,428 (0%) | 0% | 88.7 | 4,012,831 | Common Stock |
| Q2 Holdings Inc | Kirk Coleman L. | President | Sale of securities on an exchange or to another person at price $ 106.42 per share. | 10 Dec 2024 | 10,428 | 337,643 (0%) | 0% | 106.4 | 1,109,748 | Common Stock |
| Q2 Holdings Inc | Kirk Coleman L. | President | Sale of securities on an exchange or to another person at price $ 106.00 per share. | 10 Dec 2024 | 8,559 | 340,903 (0%) | 0% | 106 | 907,254 | Common Stock |
| Q2 Holdings Inc | Coleman L. Kirk | President | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 10 Dec 2024 | 7,168 | 348,071 (0%) | 0% | 0 | Common Stock | |
| Tff Pharmaceuticals Inc | Kirk Coleman | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jul 2024 | 10,184 | 45,859 (0%) | 0% | 0 | Common Stock | |
| Tff Pharmaceuticals Inc | Kirk Coleman | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jul 2024 | 10,184 | 10,184 | - | - | Stock Options (Right to Buy) | |
| Q2 Holdings Inc | Kirk L. Coleman | President | Sale of securities on an exchange or to another person at price $ 61.26 per share. | 10 Jun 2024 | 3,537 | 352,177 (0%) | 0% | 61.3 | 216,677 | Common Stock |
| Q2 Holdings Inc | Kirk L. Coleman | President | Sale of securities on an exchange or to another person at price $ 60.31 per share. | 10 Jun 2024 | 2,715 | 349,462 (0%) | 0% | 60.3 | 163,742 | Common Stock |
| Tff Pharmaceuticals Inc | Kirk Coleman | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Apr 2024 | 10,600 | 10,600 | - | - | Restricted stock units | |
| Tff Pharmaceuticals Inc | Kirk Coleman | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Apr 2024 | 5,300 | 5,300 | - | - | Restricted stock units | |
| Q2 Holdings Inc | Kirk L. Coleman | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2024 | 53,568 | 302,146 (0%) | 0% | 0 | Common Stock | |
| Q2 Holdings Inc | Kirk L. Coleman | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2024 | 26,784 | 328,930 (0%) | 0% | 0 | Common Stock | |
| Q2 Holdings Inc | Kirk L. Coleman | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2024 | 26,784 | 355,714 (0%) | 0% | 0 | Common Stock | |
| Q2 Holdings Inc | Kirk L. Coleman | President | Sale of securities on an exchange or to another person at price $ 46.50 per share. | 04 Mar 2024 | 4,437 | 248,578 (0%) | 0% | 46.5 | 206,321 | Common Stock |
| Q2 Holdings Inc | Kirk L. Coleman | President | Sale of securities on an exchange or to another person at price $ 46.01 per share. | 04 Mar 2024 | 2,904 | 253,015 (0%) | 0% | 46.0 | 133,613 | Common Stock |
| Q2 Holdings Inc | Coleman L. Kirk | President | Sale of securities on an exchange or to another person at price $ 38.31 per share. | 13 Dec 2023 | 7,007 | 258,601 (0%) | 0% | 38.3 | 268,438 | Common Stock |
| Q2 Holdings Inc | Kirk Coleman L. | President | Sale of securities on an exchange or to another person at price $ 38.31 per share. | 13 Dec 2023 | 1,498 | 257,103 (0%) | 0% | 38.3 | 57,388 | Common Stock |
| Q2 Holdings Inc | L. Coleman Kirk | President | Sale of securities on an exchange or to another person at price $ 41.18 per share. | 13 Dec 2023 | 1,184 | 255,919 (0%) | 0% | 41.2 | 48,757 | Common Stock |
| Q2 Holdings Inc | Coleman Kirk L. | President | Sale of securities on an exchange or to another person at price $ 38.31 per share. | 13 Dec 2023 | 1,083 | 265,608 (0%) | 0% | 38.3 | 41,490 | Common Stock |
| Tff Pharmaceuticals Inc | Kirk Coleman | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 0.25 per share. | 15 Aug 2023 | 20,000 | 35,675 (0%) | 0% | 0.3 | 5,000 | Common Stock |
| Q2 Holdings Inc | Kirk L. Coleman | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2023 | 35,868 | 236,119 (0%) | 0% | 0 | Common Stock | |
| Q2 Holdings Inc | Kirk L. Coleman | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2023 | 17,934 | 271,987 (0%) | 0% | 0 | Common Stock | |
| Q2 Holdings Inc | Kirk L. Coleman | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2023 | 17,934 | 254,053 (0%) | 0% | 0 | Common Stock | |
| Tff Pharmaceuticals Inc | Kirk Coleman | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Mar 2023 | 100,000 | 100,000 | - | - | Stock Options (Right to Buy) | |
| Tff Pharmaceuticals Inc | Kirk Coleman | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 0.79 per share. | 10 Mar 2023 | 12,000 | 15,675 (0%) | 0% | 0.8 | 9,457 | Common Stock |
| Q2 Holdings Inc | Kirk L. Coleman | Chief Banking Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2023 | 47,111 | 153,140 (0%) | 0% | 0 | Common Stock | |
| Q2 Holdings Inc | Kirk L. Coleman | Chief Banking Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2023 | 23,556 | 176,696 (0%) | 0% | 0 | Common Stock | |
| Q2 Holdings Inc | Kirk L. Coleman | Chief Banking Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2023 | 23,555 | 200,251 (0%) | 0% | 0 | Common Stock | |
| Q2 Holdings Inc | Kirk Coleman L. | President | Sale of securities on an exchange or to another person at price $ 37.78 per share. | 11 Feb 2023 | 5,296 | 266,691 (0%) | 0% | 37.8 | 200,083 | Common Stock |
| Q2 Holdings Inc | Kirk L. Coleman | Chief Banking Officer | Sale of securities on an exchange or to another person at price $ 27.03 per share. | 12 Dec 2022 | 2,874 | 106,029 (0%) | 0% | 27.0 | 77,684 | Common Stock |
| Q2 Holdings Inc | Kirk L. Coleman | Chief Banking Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Dec 2022 | 74,405 | 108,903 (0%) | 0% | 0 | Common Stock | |
| Tff Pharmaceuticals Inc | Kirk Coleman | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 4.40 per share. | 16 May 2022 | 1,250 | 3,250 (0%) | 0% | 4.4 | 5,500 | Common Stock |
| Tff Pharmaceuticals Inc | Kirk Coleman | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 4.83 per share. | 16 May 2022 | 425 | 3,675 (0%) | 0% | 4.8 | 2,053 | Common Stock |
| Tff Pharmaceuticals Inc | Kirk Coleman | CFO, Secretary and Treasurer | Purchase of securities on an exchange or from another person at price $ 7.30 per share. | 16 Sep 2021 | 1,000 | 2,000 (0%) | 0% | 7.3 | 7,300 | Common Stock |